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CPR cardiopulmonary resuscitation
CT
computed tomography
ECLS extracorporeal life support
ECMO extracorporeal membrane oxygenation
ICU
intensive care unit
PA
pulmonary artery
PE
pulmonary embolism
RV
right ventricle
tPA
tissue plasminogen activator
VA ECMO
veno-arterial extracorporeal membrane oxygenation
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Introduction
Cardiogenic shock that results from pulmonary embolus has a high mortality rate.
Systemic thrombolysis is frequently used in submassive and massive pulmonary
embolus and has been shown to restore circulation. However, in the event of
impending or ongoing cardiac arrest, systemic thrombolysis or anticoagulation
alone has not been always shown to be effective. Case reports have previously
established that extracorporeal membrane oxygenation can effectively be used
as an effective rescue strategy in cases of cardiac arrest as a result from
massive pulmonary embolus. We report six cases of massive pulmonary
embolism (PE), in which veno-arterial extracorporeal membrane oxygenation (VA
ECMO) was utilized or used as a backup strategy with excellent outcomes. We
highly recommend using this strategy at the bedside in a tertiary care facility
where VA ECMO support is available.

Methods
This is a retrospective study of all patients that underwent VA ECMO or utilized
VA ECMO at the bedside as a rescue strategy in the setting of massive PE. We
abstracted relevant clinical information from patient charts for this review.

Results and analysis
Out of the 107 VA ECMO runs performed at our facility between 1 September
2013 and 31 December 2014, four patients utilized this strategy in the setting of
massive PE with impending cardiac arrest; in two cases it was available to use
as a backup strategy. All six patients (Table 1) had successful recovery with
complete restoration of cognitive status, functional status, and without any clinical
signs of right ventricular (RV) dysfunction on discharge.

Case 1
We report a case of a 75-year-old African American woman with previous history
of hypertension that presented to our hospital six weeks prior to the current
admission with symptoms of left sided weakness and was found to have a
subdural hematoma. Patient underwent subdural hematoma evacuation and was
found to have a mass in the right parietal area that was completely resected and
was given the diagnosis of “Diffuse Large B Cell Lymphoma.” She was
subsequently seen by neuro-oncology and was initiated on methotrexate, folinic
acid, and rituximab. She had been doing well at home, was walking for two miles
a day, and performing activities of daily living prior to the presentation. Two days
after her second cycle of chemotherapy with methotrexate and rituximab, patient
was noted to have dizziness and hypotension and was admitted to the intensive
care unit (ICU) for further monitoring. In the ICU, patient was noted to have
progressive hypotension and she underwent a computed tomography (CT) PE
study that revealed filling defects within right and left pulmonary arteries (PAs).
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An echocardiogram confirmed severe RV dysfunction. Given her recent
craniotomy less than six weeks prior to the current presentation, systemic
thrombolytics were not a viable option. Patient was emergently taken to the
interventional suite for a catheter-directed thrombectomy with utilization of VA
ECMO. In the interventional suite, patient emergently underwent cannulation
because of severe hypotension, bradycardia and impending cardiac arrest.
During this time, patient was given moderate sedation and a decision was made
not to intubate given potential cardiovascular collapse with induction. Once
stabilized on VA ECMO with a flow of two liters per minute at 2800 revolutions
per minute, patient was able to talk and hemodynamics normalized. She
subsequently underwent catheter-directed thrombectomy using AngioJet. Patient
was then taken to the ICU and monitored for forty-eight hours on full
anticoagulation with bivalirudin. On post-ECMO day 4, a repeat echocardiogram
and CT Chest scan revealed decreased clot burden and RV strain. The ECMO
was successfully decannulated and patient was monitored in ICU for twenty-four
hours. She also underwent an inferior vena cava filter placement prior to transfer
from the intensive care unit. She was subsequently discharged home one week
later on warfarin. She was seen at one month, two month and six months followup and she reported excellent functional status. Her RV strain had significant
improved from severe to mild at the time of the six-month visit.

Case 2
A 69-year-old Caucasian woman with past medical history of hypertension,
hypothyroidism, and breast cancer status post bilateral mastectomy was doing
well and presented after an accidental fall. She sustained multiple upper limb
fractures and underwent serial surgeries over the course of a week. After the
third surgery at an outside hospital, she was noted to be hypotensive, hypoxic
and had a cardiac arrest. No thrombolytics were offered at the outside hospital
given the recent surgery. During the resuscitation, our team was called and VA
ECMO was emergently placed to stabilize the patient. Prior to the ECMO, she
was on high dose levophed, vasopressin and dopamine. After the ECMO was
placed, the pressors were weaned at our facility and CT PE protocol revealed
extensive bilateral PE with an echocardiogram that revealed severe RV
dysfunction. When patient’s RV strain had not improved after systemic
thrombolytics, the decision was made to proceed to surgical thrombectomy, and
patient had a successful pulmonary endarectomy five days after presentation.
During the procedure, she had a cardiopulmonary bypass time of sixty minutes.
She was subsequently monitored in the ICU and was closely monitored for
hemodynamic compromise. Explantation of the VA ECMO was done successfully
within twenty-four hours of the pulmonary embolectomy. Patient remained
hemodynamically stable and was weaned off sedation and subsequently
extubated four days after the VA ECMO decannulation. She had an uneventful
post-operative course and was discharged home. At nine-month follow-up, she
had a normal echocardiogram and continues to live a healthy normal life.
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Case 3
A 69-year-old gentleman with history of hypertension and diabetes mellitus was
admitted to an outside hospital with generalized weakness and was found to
have metabolic encephalopathy, diabetic ketoacidosis, and acute kidney injury.
He was treated there appropriately for diabetic ketoacidosis and was discharged
four days after admission. Prior to discharge, he had a right internal jugular
central line removed. Patient notes that by the evening of the discharge, he had
worsening dyspnea and presented to our emergency department with relative
hypotension, tachycardia and dyspnea without hypoxia. He underwent imaging
that revealed a saddle pulmonary embolus (Figure 1) and was admitted to the
medical intensive care unit for further care. His laboratory investigations were
unremarkable except for thrombocytopenia (75k). An echocardiogram revealed
severe RV dysfunction with a thrombus in transit (Figure 2). Patient was
subsequently noted to be hypotensive, but given the thrombocytopenia,
thrombolytics were thought to be a relative contraindication. Additionally,
interventional radiology refused the patient due to his unstable hemodynamic
status. After discussion with the perfusion service, a VA ECMO was available in
the interventional radiology suite in case of decompensation. Arterial and venous
access was secured for potential ECMO prior to the initiation of catheter-directed
embolectomy. Post extraction venography demonstrated no significant residual
clot. Patient was subsequently transferred to the ICU and monitored for 24 hours.
He was transitioned to warfarin and was discharged home once the INR
achieved therapeutic range. He has followed up in our center for eight months
without resulting hemodynamic consequences and displaying normal
echocardiography.

Case 4
A 48-year-old man presented to an outside hospital with gradually worsening
dyspnea on exertion over a period of three weeks. He was evaluated in the
emergency center and was found to have dilated right heart chambers on
bedside echocardiography. He was noted to be tachycardic with a heart rate at
120 beats per minute and normotensive on arrival, and a CT scan of the chest
revealed bilateral occlusive thrombus in the right and left main PAs. He was
planned to receive systemic thrombolysis, but suffered a cardiopulmonary arrest
(pulseless electrical activity). He underwent about 45 minutes of cardiopulmonary
resuscitation (CPR) in total, during which the thrombolytic (alteplase) was
administered and endotracheal intubation was performed, with brief return of
spontaneous circulation intermittently. Since he was neurologically intact
between episodes of CPR, ECMO services were called in emergently for
cardiopulmonary stabilization, and he was initiated on hypothermia protocol for
neuroprotection after instituting VA ECMO (femoral to femoral). Following this, he
was taken to the interventional radiology suite for concerning residual pulmonary
embolus post-alteplase administration and for mechanical thrombectomy.
Suction thrombectomy using an AngioJet was performed within the right PA and
following multiple passes, the majority of the clot within the right main PA was
successfully removed. There was markedly improved perfusion of the right lung
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after this. Patient was monitored in the ICU and decannulated seventy-two hours
after the VA ECMO cannulation. He was extubated within twenty-four hours after
decannulation. Patient was followed up in clinic without any further issues from
PE.

Figure 1: A representative computed tomography image of saddle
pulmonary embolus and occlusive embolus in the right main pulmonary
trunk.
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Figure 2: Two-dimensional echocardiogram displaying large echodensities
within right-sided heart chambers consistent with thrombus in transit.

Case 5
A 50-year-old previously healthy female was brought to an outside hospital after
sustaining cardiac arrest. She had a history of prolonged travel the week prior
and was noted to be diaphoretic, pale, and pulseless on the airplane. She was
resuscitated and brought to an outside hospital when our team was called to
place an emergent VA ECMO. The CT angiogram showed extensive massive PE
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and patient had forty-five minutes of CPR. An echocardiogram revealed severe
RV dysfunction. She was air lifted to our facility after cannulation by our team
with CPR in progress. She went to the operative suite for an emergent
embolectomy. Upon return from the operative suite, we weaned all the pressors
and the VA ECMO was removed on post-operative day three. She was extubated
on post-operative day six. Patient was managed on bivalirudin and bridged to
Coumadin. She was fully functional without any evidence of RV dysfunction upon
discharge home. She is being followed up by the local pulmonologist at her
hometown.

Case 6
A 61-year-old gentleman presented to outside hospital with past medical history
of prostate cancer status post radiation, meningioma status post resection with
craniotomy in 2000 and again eight months prior to current admission. He
displayed exertional angina, and unilateral lower extremity edema in the right leg.
On presentation, patient was hemodynamically unstable and was found to have a
large saddle pulmonary embolism with bilateral thrombi, and patient was
maintained on norepinephrine. An echocardiogram confirmed significant RV
strain and patient was emergently transferred to our facility. After risks and
benefits were discussed with the patient, with perfusion service as backup,
patient underwent placement of EKOS catheter into the right and left main
pulmonary arteries. A conservative dose of tissue plasminogen activator (tPA)
was chosen because of meningioma surgery and a dose of 0.5 mg per hour were
given for twenty-four hours along with fixed dose heparin at 500 units per hour.
EKOS catheters were removed at the bedside on the second day and patient
was switched to bivalirudin for increased clot burden detected on repeat CT
angiogram. Six days later, patient was taken back to the cath lab for AngioJet 6French system to lyse the clot further. He tolerated the successful debulking of
the saddle embolus and was subsequently switched to warfarin and discharged
home.
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Table 1. Brief clinical summaries for each patient case
Case 1

Case 2

Case 3

Case 4

Presentation
75-year-old African
American woman admitted
to ICU and noted to have
progressive hypotension.
CT PE and
echocardiogram revealed
RV dysfunction.
69-year-old Caucasian
lady was referred by
outside hospital during
resuscitation after surgery
from accidental upper limb
injury. CT PE and
echocardiogram revealed
extensive bilateral PE and
RV dysfunction. Patient
was on high dose
norepinephrine,
vasopressin, dopamine.
69-year old gentleman
admitted to emergency
room with relative
hypotension, tachycardia
and dyspnea without
hypoxia. He had been
discharged the same day
following treatment for
diabetic ketoacidosis.
Studies revealed a saddle
pulmonary embolus and
thrombocytopenia (75k).
Echocardiogram revealed
severe RV dysfunction
with thrombus in transit.
48-year-old normotensive
male presented with
tachycardia. CT Chest
revealed bilateral occlusive
thrombus in right and left
main PAs.

Treatment strategy
Cannulation of VA ECMO in
interventional suite due to severe
hypotension, bradycardia and
impending cardiac arrest. Patient
was not intubated given potential
cardiovascular collapse. She
underwent catheter-directed
thrombectomy using AngioJet.
VA ECMO emergently placed and
vasopressors weaned. Systemic
thrombolytics did not work, so she
underwent surgical thrombectomy
(bypass time 60 min).

Outcome
CT PE and echocardiogram on
post-ECMO day 4 showed
decreased clot burden and RV
strain. Follow up visits show
marked improvement in RV
strain from severe to mild.

Use of thrombolytics discarded due
to thrombocytopenia. VA ECMO
access was secured in
interventional radiology suite in
case of decompensation, but was
not used.

Post-extraction venography
demonstrated no significant
residual clot. ICU monitoring for
24 hours and transitioned to
Coumadin for INR stabilization.
Eight months without resulting
hemodynamic consequence
and normal echocardiography.

Planned to receive systemic
thrombolysis, but suffered
cardiopulmonary arrest. He
underwent CPR for 45 min, was
administered thrombolytic alteplase,
and intubated. Following
neurological assessment, patient
was put on VA ECMO and
underwent successful mechanical

72 hr after VA ECMO
cannulation, patient was
explanted and in follow-up
visits in clinic showed no issues
from the PE.
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echocardiogram.
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Case 5

Case 6

50-year-old female
sustaining cardiac arrest
referred by outside
hospital where she was
noted to be diaphoretic,
pale, and pulseless. CT
angiogram showed
massive EP and
underwent 45 min CPR.
Her echocardiogram
revealed severe RV
dysfunction.
61-year old man with
history of prostate cancer.
Saddle pulmonary
embolism with bilateral
thrombi maintained on
norepinephrine
Echocardiogram confirmed
significant RV strain and
emergently transferred to
our facility.

suction thrombectomy using
AngioJet.
VA ECMO was placed on patient
and she was air lifted with CPR in
progress to our facility. Here, she
underwent emergent surgical
embolectomy.

Conservative tPA doses (0.5 mg/hr)
and heparin drip (500 U/hr) were
used due to past meningioma
surgery. EKOS catheters placed
into right and left main PAs.
Bivalirudin was started on the
second day due to increased clot
burden revealed on CT angiogram.
Six days later, patient underwent
AngioJet intervention to lyse clot
further.

Pressors were weaned and VA
ECMO explanted three days
after operation. She was fully
functional without evidence of
RV dysfunction upon
discharge.

Patient tolerated debulking of
saddle embolus, switched from
bivalirudin to warfarin, and
discharged home.

Discussion
The manifestations of acute PE may range from being asymptomatic to sudden
death. Current management practices mandate early diagnosis and risk
stratification, which includes evaluation of hemodynamic parameters and of
cardiac function/impairment with a 2D echocardiogram, and biomarkers of
cardiac injury. Life threatening acute PE results from the interaction of clot
burden and underlying cardiopulmonary status, resulting in hemodynamic
instability.5 Mortality from cardiogenic shock following massive PE approaches
75%.2 Massive PE is defined as acute PE with sustained hypotension (systolic
blood pressure < 90 mmHg for at least 15 minutes or requiring inotropic support,
not due to a cause other than PE, such as arrhythmia, hypovolemia, sepsis, or
left ventricular dysfunction), pulselessness, or persistent profound bradycardia
(heart rate < 40 bpm with signs or symptoms of shock).6 The pathophysiology of
massive PE consists of direct mechanical obstruction in the pulmonary arterial
system, hypoxic vasoconstriction that increases pulmonary vascular resistance
and RV afterload. Acute RV pressure overload may then result in RV hypokinesis
and dilatation, tricuspid regurgitation, and ultimately RV failure. This presentation
in extremis is not uncommon, and such patients are often too unstable to
undergo definite management of the embolus, either successful thrombolysis
and/or embolectomy. Thrombolysis in these patients should not be delayed
because irreversible cardiogenic shock may ensue.7 Management of massive PE
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causing hemodynamic instability is challenging especially in the setting of
contraindications to systemic thrombolysis, as in three of the patients described
here. Even when patients with acute massive PE are prescreened for absolute
contraindications, the rate of major hemorrhage from systemic thrombolytic
administration is approximately 20%, including a 3% to 5% risk of hemorrhagic
stroke.8 Other modalities of treatment include catheter-directed or surgical
embolectomy.
In a systematic review of available cohort data comprising a total of 348 patients,
clinical success with percutaneous therapy alone for patients with acute massive
PE was 81% (aspiration thrombectomy 81%; fragmentation 82%; rheolytic
thrombectomy 75%) and was 95% when combined with local infusion of
thrombolytic agents (aspiration thrombectomy 100%; fragmentation 90%;
rheolytic thrombectomy 91%).13
Recommendations for Catheter-Based Treatment for Massive PE (adapted
from reference 8)
1. Depending on local expertise, either catheter embolectomy and
fragmentation or surgical embolectomy is reasonable for patients with
massive PE and contraindications to fibrinolysis (Class IIa; Level of evidence
C ).
2. Catheter embolectomy and fragmentation or surgical embolectomy is
reasonable for patients with massive PE who remain unstable after receiving
fibrinolysis (Class IIa; Level of Evidence C).
Surgical embolectomy has historically had a high mortality rate—between 20% to
30%.14 Leacche et al.[15] reported a 6% mortality rate (3 out of 47 patients) in
patients with massive PE who underwent a surgical embolectomy. However in
this series, hemodynamic instability was noted only in 26% of the patients. A
significantly higher mortality, up to 70%, has been reported in patients who
undergo cardiopulmonary resuscitation.[16] The best surgical candidates are those
patients with a large amount of clot limited to the central main PA. The decision
to proceed with catheter-based versus surgical embolectomy requires
coordinated teamwork involving the intensivist, interventional radiologist, and the
thoracic surgeon.
In hemodynamically unstable patients, prompt surgical intervention with ECMO
can be life-saving. In acute massive PE, use of extracorporeal life support
(ECLS) was first reported in 1961.[3] VA ECMO support provides cardiac and
respiratory support as it helps maintain blood flow with the help of centrifugal
roller pumps and oxygenated venous blood through a membrane oxygenator. In
addition, it corrects the resulting acidosis from respiratory failure. This
hemodynamic stabilization restores organ perfusion and allows time to enable
definitive management of PE—surgical or catheter-directed embolectomy. This is
especially helpful in emergent situations in which the femoral vein and the artery
can be easily cannulated, even in the presence of ongoing CPR. At our center,
we believe that facilitated thrombolysis utilizing VA ECMO support offers “RV
rest” and thereby rescues the patient in the setting of cardiac arrest. In these
cases, utilizing thrombolytics without appropriate resuscitation of circulatory
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arrest may not be fruitful, and utilizing VA ECMO will establish the circulatory
support so that facilitated thrombolysis may be subsequently more effective. In all
of the presented cases, we were able to decompress the acutely overloaded RV,
allowing us time to undertake a definitive management choice.
When we were able to bypass the “obstruction” to the RV with ECLS,
hemodynamic parameters improved and vasopressor requirements diminished
resulting in improved end organ perfusion, as evidenced by lactate clearance.
Following definitive treatment of the PE with the relief of the obstruction and
restoring forward flow from the RV, all patients underwent successful
decannulation of the ECMO circuit with subsequent improvement in RV function.
Maggio et al.4 reported a series of 21 patients with pulmonary embolism requiring
ECLS, with a survival rate of 62%. The mean duration of ECLS was 4.7 days;
however, 10 of the 13 survivors did not receive additional therapy other than
anticoagulation. This was based on their observation that the clot typically
undergoes significant autolysis in about 5 days. We add to this data and report
one hundred percent survival utilizing this strategy.
We hereby report a series of six patients with massive PE out of which four who
underwent initial stabilization with VA ECMO and subsequently underwent
thrombectomy (3 catheter-directed and 1 surgical) with a 100% survival to
discharge. The choice of therapy for massive PE—thrombolytics, clot
fragmentation, catheter embolectomy or surgical embolectomy—depends on the
expertise available at each institution. Currently, there are no randomized trials
addressing superiority of one therapy over the other. Although ECMO appears as
an attractive approach, potential drawbacks of using ECMO in this particular
setting should be kept in mind. These may include vascular injury during
cannulation, bleeding complications, and dislodging additional clots from the
inferior vena cava, none of which were seen in our cases. In addition, there may
be significant costs involved with instituting ECMO in patients who would have
done well with systemic thrombolysis. ECLS should be considered in patients
who are otherwise good candidates for systemic thrombolytics but who continue
to be in persistent shock despite administration of thrombolytics. It should
definitely be considered in patients with cardiopulmonary arrest due to a
pulmonary embolus.
We also prefer using direct thrombin inhibitors (bivalirudin) in patients with
significantly elevated clot burden. Bivalirudin, a direct thrombin inhibitor with
short half-life, reliable anticoagulant response, and a capacity to reduce the
thrombogenic potential of thrombin bound to clot is likely a better agent than
heparin in patients with mechanical circulatory support devices. Previous studies
utilizing bivalirudin in implantable ventricular assist devices as a first line agent
have shown that there is no incidence of thromboembolic complications, which is
similar to our experience. In one study, patients that have been on bivalirudin in
the setting of post-cardiotomy shock, bivaliruidin has been found to have a less
bleeding and less transfusion requirements, along with reduced costs. Large
scale studies need to be done to show the cost benefit analysis of bivalirudin as
a first line agent when compared to heparin.17
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We also recommend management of these patients by a multidisciplinary team
who are able to arrive to the bedside in a timely manner similar to the STEMI
pager system utilized nationwide. We recommend an algorithm (Figure 3) to riskstratify patients and suggest addition of the VA ECMO perfusion service,
interventional cardiology/radiology, cardiothoracic service and an
echocardiographer to the massive PE team in tertiary care centers where VA
ECMO is a feasible option. We have found that the availability of this service at
our institution has directly led to improved outcomes and excellent functional
status at discharge.

Figure 3: A proposed algorithm to manage massive or submassive
pulmonary embolus
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